FundedIQ
Biotechnology

Bluestem Biosciences: Funding, Investors & Team (Oct 2026)

Bluestem Biosciences, Inc., is designing biology with the end in mind to enable the existing infrastructure in the Midwest for industrialized synthetic biology.

www.bluestembiosciences.com LinkedIn Omaha, United States 1-10 employees
Biotechnology Life Science
Total raised
$5.0M
Rounds
1
Latest
Pre-Seed
Aug 2022

Bluestem Biosciences has raised $5.0M across 1 funding round on record, the most recent a Pre-Seed of $5.0M announced in Aug 2022.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Bluestem Biosciences Company Profile and Key Stats

Total funding raised
$5.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$5.0M in Aug 2022
Employees
1-10
reported band
Headquarters
Omaha, United States

Latest funding round on record: Aug 2022.

Bluestem Biosciences Funding Rounds

Date
Round
Amount
Pre-Seed
$5.0M

Bluestem Biosciences Founders and Leadership Team

Name
Role
Contact
Billy Hagstrom
CEO
Locked

Contact details for the Bluestem Biosciences team: 1 of 1 has an email address on file.

Start 14-day free trial →

Bluestem Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
6,021
$600K

Bluestem Biosciences' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Bluestem Biosciences in Biotechnology and Omaha

Companies Similar to Bluestem Biosciences

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Bluestem Biosciences Funding FAQs

What does Bluestem Biosciences do?

Bluestem Biosciences, Inc., is designing biology with the end in mind to enable the existing infrastructure in the Midwest for industrialized synthetic biology.

How much funding has Bluestem Biosciences raised?

Bluestem Biosciences has raised $5.0M across 1 round on record. The most recent is a Pre-Seed of $5.0M announced in Aug 2022.

When did Bluestem Biosciences last raise funding?

Bluestem Biosciences' most recent funding round on record is a Pre-Seed of $5.0M, announced in Aug 2022.

Who is the CEO of Bluestem Biosciences?

Billy Hagstrom is listed as CEO at Bluestem Biosciences.

Where is Bluestem Biosciences headquartered?

Bluestem Biosciences is based in Omaha, Nebraska, United States.

How many employees does Bluestem Biosciences have?

Bluestem Biosciences is in the 1-10 employee band.

How does Bluestem Biosciences' funding compare to other Biotechnology startups?

Bluestem Biosciences' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Bluestem Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bluestem Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.